Clinical Trial Update: Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and efficacy of RGT-61159 in adults with relapsed or refractory Adenoid Cystic Carcinoma or Colorectal Cancer; the trial i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Colorectal Cancer

Drugs mentioned

• RGT-61159

Snippet

Sponsor: Rgenta Therapeutics Inc | Conditions: Adenoid Cystic Carcinoma, Colorectal Cancer | Phase 1 | Status: RECRUITING